[26-000146] the laboratory applied precision omics requires qiasymphony DSP circulating DNA kit in order to isolate cfdna in plasma samples from lung transplant patient.
Ended Awarded Last action
- Contract number
- 75N92026F00001
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,691
Award facts
- Contract value 100% obligated
- $17,690.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
Award details come from SAM.gov/FPDS.
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $17,690.79 firm fixed-price BPA call to Qiagen, LLC on December 17, 2025, for delivery by March 16, 2026. The contract supports the Laboratory Applied Precision Omics program, which requires the QIAsymphony DSP Circulating DNA Kit to isolate cell-free DNA (cfDNA) from plasma samples collected from lung transplant patients. This award was issued without a set-aside designation, allowing Qiagen to compete in the open federal marketplace. Work will be performed at Qiagen's facility in Germantown, Maryland, where the company manufactures and distributes molecular diagnostics and scientific equipment.
This BPA call represents a task order against an existing blanket purchase agreement, enabling the NHLBI to efficiently procure specialized laboratory consumables and reagents needed for precision medicine research initiatives. Qiagen, a foreign-owned molecular diagnostics manufacturer with significant federal contract experience, regularly provides advanced sample preparation and molecular analysis products across multiple agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans Affairs. The cfDNA isolation kits procured under this contract support translational research efforts aimed at improving lung transplant outcomes through advanced genomic analysis capabilities.
Quick answers
Who was awarded contract 75N92026F00001?
75N92026F00001 was awarded to Qiagen, LLC by National Heart Lung and Blood Institute (National Institutes of Health) on December 17, 2025.
How much is contract 75N92026F00001 worth?
The government has obligated $17,691 on 75N92026F00001.
Is contract 75N92026F00001 an order under another contract?
Yes. 75N92026F00001 is a BPA call under 75N98024A00107, a blanket purchase agreement.
Was contract 75N92026F00001 competed?
The extent of competition for 75N92026F00001 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award